Brie Carter

Summit Therapeutics (NASDAQ:SMMT) announced the opening of a Phase 2 kidney cancer trial evaluating ivonescimab-based treatments in approximately 100 patients across two countries.

Peoples Bancorp of North Carolina (NASDAQ:PEBK) reported third-quarter 2026 net earnings of $5.7 million, up approximately 54% from $3.7 million a year earlier.

Merck (NYSE:MRK) agreed to acquire Silence Therapeutics (NASDAQ:SLN) for $20 per ADS, valuing its equity at approximately $1.3 billion.

EquipmentShare (NASDAQ:EQPT) raised its 2026 revenue forecast to $5.81–$6.05 billion, citing customer demand, fleet utilization and improving productivity.

Sunshine Silver Mining & Refining (NYSE:SSMR) completed approximately 47,600 meters of its 50,000-meter infill drilling program, advancing its planned Sunshine Mine restart in late 2028.

Cleveland-Cliffs (NYSE:CLF) reported $612 million in third-quarter adjusted EBITDA, exceeding its $575 million guidance, as revenue reached $5.6 billion.

OpenWorld (NASDAQ:OPNW) signed a definitive agreement to acquire Blocksight, supporting two proposed tokenized financing programs worth up to US$1.13 billion combined.

Evaxion (NASDAQ:EVAX) reported sustained clinical responses after three years in its phase 2 melanoma vaccine trial, with no tumor progression among six patients followed.

Solana (SOL) has gone more than two years without a major mainnet outage, according to Fidelity’s Center for Applied Technology (FCAT).

Latvia’s parliament has approved new cryptocurrency tax rules, including a one-time declaration scheme and an investment-account option.